The present invention relates to compounds useful as inhibitors of protein kinases of the following formula: ##STR00001## or a pharmaceutically acceptable salt thereof. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the inventions.

 
Web www.patentalert.com

< Modulation of glucagon receptor expression

< Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors

> Nitrogen-containing heterocyclic compounds and methods of use thereof

> 1-substituted-3-.beta.-D-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same

~ 00614